Skip to main content
Top
Published in: BMC Nephrology 1/2018

Open Access 01-12-2018 | Research article

Prevalence and associated factors of protein- energy wasting among patients with chronic kidney disease at Mulago hospital, Kampala-Uganda: a cross-sectional study

Authors: Lydia Namuyimbwa, Collins Atuheire, Joel Okullo, Robert Kalyesubula

Published in: BMC Nephrology | Issue 1/2018

Login to get access

Abstract

Background

Chronic kidney disease (CKD) is global health concern and priority. It is the 12th leading cause of death worldwide. Protein Energy Wasting occurs in 20–25% of patients with chronic kidney disease and can lead to a high morbidity and mortality rate. We determined the prevalence of protein energy wasting and factors associated among patients with chronic kidney disease at Mulago National Referral Hospital, Kampala, Uganda.

Methods

We conducted a cross-sectional study recruiting 182 (89 non-CKD patients and 93 CKD patients) consecutively from the outpatient clinic and wards on New Mulago Hospital complex. We took anthropometric measurements including heights, weights, Triceps skin fold (TSF), Mid- Upper Arm circumference (MUAC), Body Mass Index (BMI) and Mid-arm muscle circumference (MAMC). Serum albumin levels and lipid profile levels were also obtained. Following consent of study participants, Data was collected using questionnaires and analyzed using STATA 14.1. Percentages, frequencies, means, medians, standard deviation and interquartile range were used to summarise data. Crude and adjusted binary logistic regression was performed to assess unadjusted and adjusted effect measures of protein energy wasting due to several factors. Stratification by CKD status was performed during the analysis to minimize confounding.

Results

The median age for CKD patients was 39 years compared to 27 years for non-CKD participants (p < 0.001). The prevalence of protein energy wasting (PEW) was 68.6% in this study with 47.3 and 21.3% among CKD and non-CKD participants respectively. Factors which were associated with PEW included CKD age between 18 and 24, being single, catholic religion, CKD stage 4, Hb < 11.5 g/dl and LDL > 160 mg/dl.

Conclusion

Protein energy Wasting is prevalent among patients with chronic kidney disease and clinicians should routinely screen for it during patient care.
Appendix
Available only for authorised users
Literature
2.
go back to reference Krzesinski J-M, Sumaili KE, Cohen E. How to tackle the avalanche of chronic kidney disease in sub-Saharan Africa: the situation in the Democratic Republic of Congo as an example. Nephrol Dial Transplant. 2007;22(2):332–5.CrossRefPubMed Krzesinski J-M, Sumaili KE, Cohen E. How to tackle the avalanche of chronic kidney disease in sub-Saharan Africa: the situation in the Democratic Republic of Congo as an example. Nephrol Dial Transplant. 2007;22(2):332–5.CrossRefPubMed
4.
go back to reference Schwartz JI, et al. Looking at non-communicable diseases in Uganda through a local lens: an analysis using locally derived data. Glob Health. 2014;10(1):77.CrossRef Schwartz JI, et al. Looking at non-communicable diseases in Uganda through a local lens: an analysis using locally derived data. Glob Health. 2014;10(1):77.CrossRef
5.
go back to reference Kovesdy CP, Kopple JD, Kalantar-Zadeh K. Management of protein-energy wasting in non-dialysis-dependent chronic kidney disease: reconciling low protein intake with nutritional therapy. Am J Clin Nutr. 2013;97(6):1163–77.CrossRefPubMedPubMedCentral Kovesdy CP, Kopple JD, Kalantar-Zadeh K. Management of protein-energy wasting in non-dialysis-dependent chronic kidney disease: reconciling low protein intake with nutritional therapy. Am J Clin Nutr. 2013;97(6):1163–77.CrossRefPubMedPubMedCentral
6.
go back to reference Agaba EI, Agaba PA. Prevalence of malnutrition in Nigerians with chronic renal failure. Int Urol Nephrol. 2003;36(1):89–93.CrossRef Agaba EI, Agaba PA. Prevalence of malnutrition in Nigerians with chronic renal failure. Int Urol Nephrol. 2003;36(1):89–93.CrossRef
7.
go back to reference Fouque D, et al. A proposed nomenclature and diagnostic criteria for protein–energy wasting in acute and chronic kidney disease. Kidney Int. 2008;73(4):391–8.CrossRefPubMed Fouque D, et al. A proposed nomenclature and diagnostic criteria for protein–energy wasting in acute and chronic kidney disease. Kidney Int. 2008;73(4):391–8.CrossRefPubMed
8.
go back to reference Fouque D, et al. A proposed nomenclature and diagnostic criteria for protein–energy wasting in acute and chronic kidney disease. Int Soc Nephrol. 2008;73:391–8. Fouque D, et al. A proposed nomenclature and diagnostic criteria for protein–energy wasting in acute and chronic kidney disease. Int Soc Nephrol. 2008;73:391–8.
9.
go back to reference O’Callaghan CA, Shine B, Lasserson DS. Chronic kidney disease: a large-scale population-based study of the effects of introducing the CKD-EPI formula for eGFR reporting. BMJ Open. 2011;1:e000308.PubMedPubMedCentral O’Callaghan CA, Shine B, Lasserson DS. Chronic kidney disease: a large-scale population-based study of the effects of introducing the CKD-EPI formula for eGFR reporting. BMJ Open. 2011;1:e000308.PubMedPubMedCentral
10.
go back to reference Agaba EI, Agaba PA. Prevalence of malnutrition in Nigerians with chronic renal failure. Int Urol Nephrol. 2004;36(1):89–93.CrossRefPubMed Agaba EI, Agaba PA. Prevalence of malnutrition in Nigerians with chronic renal failure. Int Urol Nephrol. 2004;36(1):89–93.CrossRefPubMed
11.
go back to reference Srivastava N, et al. Protein energy wasting in chronic kidney disease patients: a hospital based study. Indian J Prev Soc Med. 2012;43(4):390. Srivastava N, et al. Protein energy wasting in chronic kidney disease patients: a hospital based study. Indian J Prev Soc Med. 2012;43(4):390.
12.
go back to reference Peter Stenvinkel RP-F, Lindholm B. Leptin, ghrelin and proinflammatory cytokines: compounds with nutritional impact in chronic kidney disease? Adv Chronic Kidney Dis. 2003;10(4):332–45. Peter Stenvinkel RP-F, Lindholm B. Leptin, ghrelin and proinflammatory cytokines: compounds with nutritional impact in chronic kidney disease? Adv Chronic Kidney Dis. 2003;10(4):332–45.
13.
go back to reference Kuhlmann MK, et al. OPTA—malnutrition in chronic renal failure. Nephrol Dial Transplant. 2007;22(suppl_3):iii13–9. Kuhlmann MK, et al. OPTA—malnutrition in chronic renal failure. Nephrol Dial Transplant. 2007;22(suppl_3):iii13–9.
14.
go back to reference Agaba I, et al. Serum lipids in pre Dialysis chronic renal failure patients in Jos University teaching hospital, Nigeria. Highland Med Res J. 2003;1(3):13–7. Agaba I, et al. Serum lipids in pre Dialysis chronic renal failure patients in Jos University teaching hospital, Nigeria. Highland Med Res J. 2003;1(3):13–7.
15.
go back to reference Mamuye B. Assessement of Protein Energy Wasting in Patients with Chronic Kidney disease attending Renal Unit at Tikuranbesa specialised hospital. Addis Ababa University: 2016. Mamuye B. Assessement of Protein Energy Wasting in Patients with Chronic Kidney disease attending Renal Unit at Tikuranbesa specialised hospital. Addis Ababa University: 2016.
16.
go back to reference Adejumo OA, et al. Serum C-reactive protein levels in pre-dialysis chronic kidney disease patients in southern Nigeria. Ghana Med J. 2016;50(1):31–8.CrossRefPubMedPubMedCentral Adejumo OA, et al. Serum C-reactive protein levels in pre-dialysis chronic kidney disease patients in southern Nigeria. Ghana Med J. 2016;50(1):31–8.CrossRefPubMedPubMedCentral
Metadata
Title
Prevalence and associated factors of protein- energy wasting among patients with chronic kidney disease at Mulago hospital, Kampala-Uganda: a cross-sectional study
Authors
Lydia Namuyimbwa
Collins Atuheire
Joel Okullo
Robert Kalyesubula
Publication date
01-12-2018
Publisher
BioMed Central
Published in
BMC Nephrology / Issue 1/2018
Electronic ISSN: 1471-2369
DOI
https://doi.org/10.1186/s12882-018-0920-7

Other articles of this Issue 1/2018

BMC Nephrology 1/2018 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.